Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY4R | P50391 | 12/20 | 0.61 |
| ▸ | NPY1R | P25929 | 7/20 | 0.61 |
| ▸ | NPY2R | P49146 | 5/20 | 0.61 |
| ▸ | NPY5R | Q15761 | 5/20 | 0.61 |
| ▸ | GNPAT | O15228 | 1/20 | 0.55 |
| ▸ | FNTA | P49354 | 3/20 | 0.49 |
| ▸ | FNTB | P49356 | 3/20 | 0.49 |
| ▸ | PGGT1B | P53609 | 3/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29577090 | 1.00 | NPY4R (0.61) | NPY4RNPY1RNPY2RNPY5RGNPAT | |
| SCHEMBL4048021 | 1.00 | NPY4R (0.61) | NPY4RNPY1RNPY2RNPY5RGNPAT | |
| SCHEMBL31184527 | 1.00 | NPY4R (0.61) | NPY4RNPY1RNPY2RNPY5RGNPAT | |
| SCHEMBL29652151 | 0.99 | NPY4R (0.63) | NPY4RNPY1RNPY2RNPY5RGNPAT | |
| SCHEMBL31184554 | 0.97 | NPY4R (0.58) | NPY4RNPY1RNPY2RNPY5RGNPAT | |
| SCHEMBL31184355 | 0.97 | NPY4R (0.58) | NPY4RNPY1RNPY2RNPY5RGNPAT | |
| SCHEMBL29370061 | 0.97 | NPY4R (0.63) | NPY4RNPY1RNPY2RNPY5RGNPAT | |
| SCHEMBL29652138 | 0.97 | NPY4R (0.63) | NPY4RNPY1RNPY2RNPY5RGNPAT | |
| SCHEMBL29652147 | 0.97 | NPY4R (0.63) | NPY4RNPY1RNPY2RNPY5RGNPAT | |
| SCHEMBL29652153 | 0.97 | NPY4R (0.63) | NPY4RNPY1RNPY2RNPY5RGNPAT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116606369-A | Spirulina immunoregulatory peptide and preparation method and application thereof | 齐鲁工业大学(山东省科学院) | 2023-08-18 | — | — | CN | claimed |
| CN-115028704-B | Enzymolysis-resistant antibacterial peptide N1 and preparation method and application thereof | 东北农业大学 | 2023-07-07 | — | — | CN | claimed |
| CN-115028704-A | Anti-enzymolysis antibacterial peptide N1, and preparation method and application thereof | 东北农业大学 | 2022-09-09 | — | — | CN | claimed |
| CN-116606369-A | Spirulina immunoregulatory peptide and preparation method and application thereof | 齐鲁工业大学(山东省科学院) | 2023-08-18 | — | — | CN | disclosed |
| CN-115028704-B | Enzymolysis-resistant antibacterial peptide N1 and preparation method and application thereof | 东北农业大学 | 2023-07-07 | — | — | CN | disclosed |
| CN-115028704-B | Enzymolysis-resistant antibacterial peptide N1 and preparation method and application thereof | 东北农业大学 | 2023-07-07 | — | — | CN | disclosed |
| CN-115028704-A | Anti-enzymolysis antibacterial peptide N1, and preparation method and application thereof | 东北农业大学 | 2022-09-09 | — | — | CN | disclosed |
| CN-115028704-A | Anti-enzymolysis antibacterial peptide N1, and preparation method and application thereof | 东北农业大学 | 2022-09-09 | — | — | CN | disclosed |
| WO-2022128940-A1 | POLYMER COMPOUND COMPRISING PENDENT PEPTIDES, METHOD FOR PREPARING SAME AND USES THEREOF | GENEPEP (FR) | 2022-06-23 | — | — | WO | disclosed |
| EP-4011932-A1 | POLYMER COMPOUND WITH PENDANT PEPTIDES, METHOD FOR PREPARING SAME AND USES THEREOF | Genepep (FR) | 2022-06-15 | — | — | EP | disclosed |
| CN-103245747-B | Method for predicating metabolizable energy level of pig diets by metabonomics technology | UNIV CHINA AGRICULTURAL | 2015-05-27 | — | — | CN | disclosed |
| CN-103245747-A | Method for predicating metabolizable energy level of pig diets by metabonomics technology | UNIV CHINA AGRICULTURAL | 2013-08-14 | — | — | CN | disclosed |
| EP-1748786-A4 | DALBAVANCIN COMPOSITIONS FOR TREATMENT OF BACTERIAL INFECTIONS | VICURON PHARM INC (US) | 2009-07-15 | — | — | EP | disclosed |
| EP-1748786-A2 | DALBAVANCIN COMPOSITIONS FOR TREATMENT OF BACTERIAL INFECTIONS | Vicuron Pharmaceuticals, Inc. (US) | 2007-02-07 | — | — | EP | disclosed |
| WO-2006078277-A2 | DALBAVANCIN COMPOSITIONS FOR TREATMENT OF BACTERIAL INFECTIONS | VICURON PHARMACEUTICALS INC. (US) | 2006-07-27 | — | — | WO | disclosed |